RE:RE:30 Bucks Cmed has put off the vote on HIP for a couple of more days. HIP had acquired a license siince ACB’s initial offer, which may make them more palatable to ACB. If Cmed shareholders vote to determine acceptance of HIP or not, I’m confident that there will an overwhelming flat out rejection of this merger. ACB has too much going for it now for Cmed to walk away, with contracts in Germany and Italy etc. If both companies merge, they could be come a powerhouse quickly. Without Cmed, it will take Acb a bit longer, but will get there.